Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

The Economist Events' Pharma Summit 2015: The Dawn of a New Era


News provided by

The Economist Pharma Summit

23 Feb, 2015, 09:00 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, February 23, 2015 /PRNewswire/ --

Challenges impacting the world of pharma as well as the innovation required to face them 

Tweet your questions ahead of the Pharma Summit 2015 via @EconomistEvents #pharmasummit 

The Pharma Summit, now in its 21st year, is a must-attend event for industry leaders. The Summit provides a unique platform for stakeholders from across the industry to convene, share views and network with peers. This year's theme, 'The dawn of a new era', will observe the challenges the industry is facing as well as the innovation required to face them.

The annual Pharma Summit will be held in London on Thursday, February 26th2015 at The Radisson Blu Portman Hotel, London, from 9:00am to 5:30pm.

Kieran Murphy, a panel speaker and President and Chief Executive Officer, Life Sciences, GE Healthcare, commented:  

"The technology promise in healthcare has never been more exciting, with the convergence of precision medicine, big data, analytics and the industrial internet, on top of breakthroughs in biologics, gene and immuno-therapies. Can the industry speed up and will payers pay up? This Pharma Summit will focus on how industry can innovate and collaborate to bring better, more effective and affordable medicine to more people, and still meet business objectives.  I am looking forward to the meeting, the panels and the lively discussions it will provoke."  

The Pharma Summit will address areas such as improving access and affordability of medicines, the immense differences between developed and emerging markets, technology in pharma, and enhancing partnerships across the ecosystem to benefit all. The event will bring together leading voices representing global pharmaceutical companies, patient associations, non-profit organisations, regulators and field experts to continue providing the most relevant insight, invaluable to the pharma industry.

Key speakers at the Summit include: 

  • Guido Rasi, Principal Adviser in Charge of Strategy, European Medicines Agency
  • Andrew Hotchkiss, President, Australia, Canada and Europe, Lilly
  • Maureen Baker, Chair, Royal College of General Practitioners
  • Sir Michael Hirst, President, International Diabetes Federation
  • Manica Balasegaram, Executive Director - Access Campaign, Medecins Sans Frontieres
  • Richard Barker, Director, CASMI (Centre for the Advancement of Sustainable Medical Innovation)
  • Francois Bernard, Head of Market Access and Communications, MundiPharma
  • Alison Clough,  Executive Director Commercial UK, Association of the British Pharmaceutical Industry
  • Sir Andrew Dillon, Chief Executive Officer, National Institute of Health and Clinical Excellence (NICE)
  • Jeremy Farrar, Director, Wellcome Trust
  • Patrick Flochel, Partner, Global Pharmaceutical Sector Leader, Global Life Sciences Centre, EY
  • Michel Goldman, former Executive Director, Innovative Medicines Initiative (IMI)
  • Matthias Gottwald, Head Research and Development Policy and Networking, Bayer Healthcare Pharmaceuticals
  • Janet Hammond, Global Head and Senior Vice-president, Infectious Diseases Discovery and Translational Area, Roche Pharma Research and Early Development
  • James Heywood, Chairman and Co-founder, Patients Like Me
  • Heidi Hunter, Head of Biosimilars Business Unit, Boehringer-Ingelheim
  • Stefan Kapferer, Deputy Secretary-General, OECD
  • Nuria Mas, Professor of Economics, IESE Business School
  • David McMillan, Chief Executive Officer, Europe, Aviva
  • Duncan Moore, Partner, East West Capital Partners
  • Jeremy Morgan, International Vice-president Diabetes, Lilly
  • Kieran Murphy, President & Chief Executive Officer, GE Healthcare Life Sciences
  • Vivek Muthu, Chair, Economist Intelligence Unit Healthcare
  • Vas Narasiham, Global Head of Development, Novartis
  • Diem Nguyen, General Manager, LOE Portfolio Head, US Promoted Brands, Pfizer
  • Jim O'Neill, Chair, Review on Antimicrobial Resistance
  • David Solomon, Chief Executive Officer, Bionor Pharma
  • Adrian Thomas, Vice-president Global Market Access, Commercial Strategy Operations and Global Public Health, Janssen
  • Bart Vannieuwenhuyse, Senior Director of Health Information Sciences, Janssen
  • John Watson, Deputy Chief Medical Officer, UK Department of Health
  • Pascale Witz, Executive Vice-president Global Divisions & Strategic Development, Sanofi

For more information and to view the full programme please visit: http://www.pharmasummit.economist.com

Follow the Pharma Summit via @EconomistEvents #pharmasummit on Twitter to get the latest updates, submit your questions, and join in with discussions on the day.

About The Economist Events 

The Economist Events' philosophy is to tackle issues with a forward-looking, uniquely global perspective. We aim to create events for the intellectually curious: people who enjoy ideas and who are passionate about the issues that define our world.

Attend our events: http://www.economistinsights.com/events

Platinum sponsor: EY 

EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.

This news release has been issued by EYGM Limited, a member of the global EY organization that also does not provide any services to clients.

Gold sponsor: IESE
IESE Business School, the graduate school of management of the University of Navarra, is consistently ranked among the world's leading business schools. Highly international, the school is committed to the education and development of responsible business leaders worldwide. It offers high calibre degree and executive education programmes, and conducts rigorous research initiatives that are global in scope.

In addition to world class campuses in Barcelona and Madrid, the school has a centre in New York City and offices in London, Munich and Sao Paulo. It also delivers programmes at numerous other locations, including Miami, Dubai and Shanghai. IESE launched Europe's first two-year MBA programme in 1964 under the guidance of Harvard Business School and it also pioneered the concept of executive education for business leaders in Europe.

About Consilium Strategic Communications 

Consilium Strategic Communications is a global leader in providing trusted, healthcare-focused strategic IR and financial PR counsel to corporations, Boards, senior decision makers and executives. From offices in Europe and USA, Consilium's senior team provides cross-border comprehensive financial and corporate healthcare communications advice to some of the world's most prominent and innovative corporations around-the-clock. The Company has established deep knowledge across all areas of the global healthcare sector through broad experience in representing international clients spanning the Fortune 500, FTSE100, FTSEurofirst 300, FTSE250, Euronext and AIM through to discrete specialist reputation management and crisis projects. For more information please visit our website at http://www.consilium-comms.com.

Press enquiries
For further information on event registration or to request interviews with any of the speakers at the Pharma Summit 2015, please contact Consilium Strategic Communications, Official Press Office for The Economist Healthcare Events:

Lindsey Neville or Liza Carr
Email: pharmasummit2015@consilium-comms.com
Tel: +44(0)20-3709-5700

For general queries or further information about the event please call +44(0)207-576-8118 or e-mail emeaevents@economist.com

Want more from The Economist Events?
Join us on Twitter: @EconomistEvents

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.